Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,571 Blood Cancer
clinical trials

Oncology Clinical Trial
A Phase 3 Extension Study of Duvelisib and Ofatumumab in Patients With CLL/SLL Previously Enrolled in Study IPI-145-07
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 3 Extension Study of Duvelisib and Ofatumumab in Patients With CLL/SLL Previously Enrolled in Study IPI-145-07
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 3 Extension Study of Duvelisib and Ofatumumab in Patients With CLL/SLL Previously Enrolled in Study IPI-145-07
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Venice, FL
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Dana Farber Cancer Institution
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cancer Treatment Centers of America-Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mayo Clinic - MN
mi
from
Rochester, MN
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Downey Medical Center
mi
from
Downey, CA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Winthrop Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Baker City
mi
from
Baker City, OR
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Indu and Raj Soin Medical Center
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
The Women's Imaging Center
mi
from
Denver, CO
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Beaumont Hospital - Farmington Hills
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Lymphoma Clinic of Michigan
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada-Horizon Ridge
mi
from
Henderson, NV
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Center of The South Incorporated
mi
from
Houma, LA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
OhioHealth Mansfield Hospital
mi
from
Mansfield, OH
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Marshfield Medical Center
mi
from
Marshfield, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Nebraska Medicine-Village Pointe
mi
from
Omaha, NE
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health - Park Rapids
mi
from
Park Rapids, MN
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Charles Health System-Redmond
mi
from
Redmond, OR
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Regional West Medical Center Cancer Center
mi
from
Scottsbluff, NE
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Geisinger Medical Oncology-Selinsgrove
mi
from
Selinsgrove, PA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Bhadresh Nayak MD PC-Sterling Heights
mi
from
Sterling Heights, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cotton O'Neil Cancer Center / Stormont Vail Health
mi
from
Topeka, KS
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Gene Upshaw Memorial Tahoe Forest Cancer Center
mi
from
Truckee, CA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Professional Building
mi
from
Warren, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Wright-Patterson Medical Center
mi
from
Wright-Patterson Air Force Base, OH
Click here to add this to my saved trials
Myelodysplastic Syndrome Clinical Trial
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Myelodysplastic Syndrome Clinical Trial
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Myelodysplastic Syndrome Clinical Trial
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Myelodysplastic Syndrome Clinical Trial
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, OR
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Beaumont Hospital - Farmington Hills
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Nebraska Medicine-Village Pointe
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Wright-Patterson Medical Center
mi
from
Wright-Patterson Air Force Base, OH
Click here to add this to my saved trials
Oncology, Other Clinical Trial
S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)
Status: Enrolling, Phase I
Updated: 5/11/2017
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Caba,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Ascension Saint John Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford
mi
from
Stanford, CA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Elevate CLL TN: Study of Obinutuzumab + Chlorambucil, Acalabrutinib (ACP-196) + Obinutuzumab, and Acalabrutinib in Subjects With Previously Untreated CLL
Status: Enrolling, Phase III
Updated: 8/8/2016
Yakima Valley Memorial Hospital/North Star Lodge
mi
from
Yakima, WA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Safety and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Safety and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling, Phase I
Updated: 12/31/1969
New York Uni Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL or Richter's Transformation
Status: Enrolling, Phase I, II
Updated: 12/31/1969
TG Therapeutics Clinical Support Team
mi
from
Seattle, WA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Lenalidomide Maintenance in Plasma Cell Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Lenalidomide Maintenance in Plasma Cell Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Nassau
mi
from
Uniondale, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Minnesota Physicians Bone Marrow Transplant Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Seattle Cancer Care Alliance (SCCA)
mi
from
Seattle, WA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology - Allen
mi
from
Allen, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Southeast Georgia Physician Associates Hematology & Oncology
mi
from
Brunswick, GA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Mercy Research
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Rocky Mountain Cancer Centers, LLP- Sky Ridge
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Meridian Health Systems
mi
from
Neptune, NJ
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Hematology & Oncology Associates of Northeastern PA
mi
from
Scranton, PA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Healthcare Research Network III, LLC
mi
from
Tinley Park, IL
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Good Samaritan Hospital
mi
from
Vincennes, IN
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Prairie Lakes Hospital
mi
from
Watertown, SD
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology-P.A.- Webster
mi
from
Webster, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Sylvester Cancer Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Niles, IL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Skokie, IL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Springfield, OR
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Waco, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Yakima, WA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Luke'S Mountain State Tumor Institute
mi
from
Boise, ID
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Monroe Carell Jr Children'S Hosp. At Vanderbilt Tower
mi
from
Nashville, TN
Click here to add this to my saved trials